MARKET

NSTG

NSTG

Nanostring Techn
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.20
-0.05
-0.33%
After Hours: 15.20 0 0.00% 16:01 05/17 EDT
OPEN
15.70
PREV CLOSE
15.25
HIGH
16.14
LOW
14.68
VOLUME
906.87K
TURNOVER
0
52 WEEK HIGH
70.40
52 WEEK LOW
13.52
MARKET CAP
705.52M
P/E (TTM)
-5.4633
1D
5D
1M
3M
1Y
5Y
Further weakness as NanoString Technologies (NASDAQ:NSTG) drops 29% this week, taking one-year losses to 73%
Even the best investor on earth makes unsuccessful investments. But it should be a priority to avoid stomach churning...
Simply Wall St. · 5d ago
What 4 Analyst Ratings Have To Say About NanoString Technologies
Analysts have provided the following ratings for NanoString Technologies (NASDAQ:NSTG) within the last quarter:
Benzinga · 6d ago
Recap: NanoString Technologies Q1 Earnings
NanoString Technologies (NASDAQ:NSTG) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Benzinga · 05/10 22:20
BRIEF-Nanostring Technologies Releases Results For First Quarter Of 2022
reuters.com · 05/10 20:56
NanoString Technologies Q1 EPS $(0.86) Misses $(0.56) Estimate, Sales $31.08M Miss $33.59M Estimate
NanoString Technologies (NASDAQ:NSTG) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.56) by 53.57 percent. This is a 38.71 percent decrease over losses of $(0.62) per
Benzinga · 05/10 20:12
-- Earnings Flash (NSTG) NANOSTRING TECHNOLOGIES Posts Q1 Loss $-0.86
MT Newswires · 05/10 16:05
Earnings Scheduled For May 10, 2022
  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Benzinga · 05/10 09:18
NanoString Appoints Dr. Teresa Foy to Board of Directors
SEATTLE, April 18, 2022--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the appointment of Dr. Teresa (Teri) Foy to the Board of Directors, effective April 18...
Business Wire · 04/18 20:00
More
No Data
Learn about the latest financial forecast of NSTG. Analyze the recent business situations of Nanostring Techn through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
33.33%Buy
16.67%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NSTG stock price target is 34.40 with a high estimate of 42.00 and a low estimate of 30.00.
High42.00
Average34.40
Low30.00
Current 15.20
EPS
Actual
Estimate
-0.69-0.52-0.34-0.17
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 246
Institutional Holdings: 64.80M
% Owned: 139.61%
Shares Outstanding: 46.42M
TypeInstitutionsShares
Increased
70
4.87M
New
24
2.85M
Decreased
54
4.36M
Sold Out
35
2.63M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.93%
Healthcare Equipment & Supplies
+2.38%
Key Executives
Non-Executive Chairman/Independent Director
William Young
President/Chief Executive Officer/Director
R. Bradley Gray
Chief Financial Officer
K. Thomas Bailey
Senior Vice President/Chief Scientific Officer
Joseph Beechem
Other
John Gerace
Director
Teresa Foy
Independent Director
Elisha Finney
Independent Director
Janet George
Independent Director
Don Kania
Independent Director
Kirk Malloy
Independent Director
Gregory Norden
Independent Director
Dana Rollison
Independent Director
Charles Waite
No Data
No Data
About NSTG
NanoString Technologies, Inc. develops, manufactures, and sells products of biological material. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. It uses its core technology to develop tools for scientific and clinical research. It offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.

Webull offers kinds of NanoString Technologies Inc stock information, including NASDAQ:NSTG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSTG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NSTG stock methods without spending real money on the virtual paper trading platform.